Neovacs SA (France) Price History
ALNEV Stock | EUR 0.0002 0.0001 33.33% |
If you're considering investing in Neovacs Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neovacs SA stands at 0.0002, as last reported on the 2nd of December, with the highest price reaching 0.0003 and the lowest price hitting 0.0002 during the day. Neovacs SA appears to be out of control, given 3 months investment horizon. Neovacs SA has Sharpe Ratio of 0.026, which conveys that the firm had a 0.026% return per unit of risk over the last 3 months. By analyzing Neovacs SA's technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please exercise Neovacs SA's Downside Deviation of 33.7, mean deviation of 12.47, and Risk Adjusted Performance of 0.0208 to check out if our risk estimates are consistent with your expectations.
Neovacs Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neovacs |
Sharpe Ratio = 0.026
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ALNEV | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
23.28 actual daily | 96 96% of assets are less volatile |
Expected Return
0.6 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Neovacs SA is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neovacs SA by adding it to a well-diversified portfolio.
Neovacs SA Stock Price History Chart
There are several ways to analyze Neovacs Stock price data. The simplest method is using a basic Neovacs candlestick price chart, which shows Neovacs SA price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 10, 2024 | 8.0E-4 |
Lowest Price | November 26, 2024 | 1.0E-4 |
Neovacs SA December 2, 2024 Stock Price Synopsis
Various analyses of Neovacs SA's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neovacs Stock. It can be used to describe the percentage change in the price of Neovacs SA from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neovacs Stock.Neovacs SA Price Rate Of Daily Change | 0.67 | |
Neovacs SA Price Daily Balance Of Power | (1.00) |
Neovacs SA December 2, 2024 Stock Price Analysis
Neovacs Stock Price History Data
The price series of Neovacs SA for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 0.0 with a coefficient of variation of 51.97. The prices are distributed with arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company had 10000:1 stock split on 31st of August 2024.Open | High | Low | Close | Volume | ||
12/02/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0002 | ||
11/29/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0002 | 16,213,174 | |
11/28/2024 | 0.0003 | 0.0004 | 0.0002 | 0.0003 | 225,630,750 | |
11/27/2024 | 0.0002 | 0.0002 | 0.0001 | 0.0002 | 23,959,503 | |
11/26/2024 | 0.0003 | 0.0003 | 0.0001 | 0.0001 | 56,189,872 | |
11/25/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0002 | 33,103,211 | |
11/22/2024 | 0.0002 | 0.0003 | 0.0001 | 0.0002 | 41,395,223 | |
11/21/2024 | 0.0003 | 0.0003 | 0.0001 | 0.0002 | 52,097,121 | |
11/20/2024 | 0.0003 | 0.0003 | 0.0001 | 0.0002 | 23,364,381 | |
11/19/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0002 | 34,323,953 | |
11/18/2024 | 0.0003 | 0.0003 | 0.0001 | 0.0002 | 43,540,980 | |
11/15/2024 | 0.0003 | 0.0003 | 0.0001 | 0.0002 | 50,392,006 | |
11/14/2024 | 0.0002 | 0.0003 | 0.0001 | 0.0002 | 18,758,170 | |
11/13/2024 | 0.0002 | 0.0003 | 0.0001 | 0.0002 | 39,875,578 | |
11/12/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0002 | 108,404,094 | |
11/11/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0002 | 30,046,061 | |
11/08/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0002 | 16,890,285 | |
11/07/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0002 | 35,058,030 | |
11/06/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0002 | 36,125,761 | |
11/05/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0002 | 31,303,927 | |
11/04/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0003 | 26,063,271 | |
11/01/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0002 | 65,008,331 | |
10/31/2024 | 0.0003 | 0.0004 | 0.0002 | 0.0002 | 44,752,167 | |
10/30/2024 | 0.0003 | 0.0004 | 0.0002 | 0.0004 | 14,050,542 | |
10/29/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0003 | 21,302,292 | |
10/28/2024 | 0.0003 | 0.0004 | 0.0002 | 0.0002 | 55,462,025 | |
10/25/2024 | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 3,461,423 | |
10/24/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0003 | 19,798,902 | |
10/23/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0003 | 23,526,686 | |
10/22/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0002 | 6,211,152 | |
10/21/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0002 | 44,937,289 | |
10/18/2024 | 0.0003 | 0.0003 | 0.0002 | 0.0002 | 12,418,797 | |
10/17/2024 | 0.0002 | 0.0003 | 0.0002 | 0.0002 | 53,174,121 | |
10/16/2024 | 0.0003 | 0.0004 | 0.0002 | 0.0002 | 149,154,452 | |
10/15/2024 | 0.0004 | 0.0004 | 0.0003 | 0.0003 | 8,217,380 | |
10/14/2024 | 0.0004 | 0.0005 | 0.0003 | 0.0003 | 100,082,225 | |
10/11/2024 | 0.0005 | 0.0005 | 0.0004 | 0.0004 | 10,116,954 | |
10/10/2024 | 0.0004 | 0.0005 | 0.0004 | 0.0004 | 21,503,820 | |
10/09/2024 | 0.0005 | 0.0005 | 0.0004 | 0.0004 | 31,601,641 | |
10/08/2024 | 0.0006 | 0.0008 | 0.0004 | 0.0004 | 322,606,716 | |
10/07/2024 | 0.0005 | 0.0006 | 0.0005 | 0.0005 | 8,867,037 | |
10/04/2024 | 0.0006 | 0.0006 | 0.0005 | 0.0005 | 11,462,796 | |
10/03/2024 | 0.0006 | 0.0006 | 0.0005 | 0.0005 | 2,715,081 | |
10/02/2024 | 0.0006 | 0.0006 | 0.0005 | 0.0006 | 16,676,980 | |
10/01/2024 | 0.0005 | 0.0006 | 0.0005 | 0.0006 | 2,983,051 | |
09/30/2024 | 0.0006 | 0.0006 | 0.0005 | 0.0006 | 24,653,131 | |
09/27/2024 | 0.0005 | 0.0006 | 0.0005 | 0.0006 | 21,003,573 | |
09/26/2024 | 0.0005 | 0.0006 | 0.0005 | 0.0006 | 9,356,111 | |
09/25/2024 | 0.0006 | 0.0006 | 0.0005 | 0.0006 | 4,450,996 | |
09/24/2024 | 0.0005 | 0.0006 | 0.0005 | 0.0006 | 4,542,750 | |
09/23/2024 | 0.0006 | 0.0006 | 0.0005 | 0.0006 | 2,512,810 | |
09/20/2024 | 0.0007 | 0.0007 | 0.0006 | 0.0006 | 59,085,195 | |
09/19/2024 | 0.0007 | 0.0007 | 0.0006 | 0.0006 | 29,670,499 | |
09/18/2024 | 0.0007 | 0.0008 | 0.0006 | 0.0007 | 50,020,131 | |
09/17/2024 | 0.0006 | 0.0007 | 0.0006 | 0.0006 | 19,208,641 | |
09/16/2024 | 0.0007 | 0.0007 | 0.0006 | 0.0006 | 12,048,300 | |
09/13/2024 | 0.0006 | 0.0007 | 0.0005 | 0.0006 | 7,079,045 | |
09/12/2024 | 0.0006 | 0.0006 | 0.0006 | 0.0006 | 4,465,300 | |
09/11/2024 | 0.0008 | 0.0008 | 0.0005 | 0.0005 | 79,551,402 | |
09/10/2024 | 0.0007 | 0.0008 | 0.0006 | 0.0008 | 17,044,932 | |
09/09/2024 | 0.0007 | 0.0007 | 0.0006 | 0.0007 | 3,510,002 |
About Neovacs SA Stock history
Neovacs SA investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neovacs is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neovacs SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neovacs SA stock prices may prove useful in developing a viable investing in Neovacs SA
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. Neovacs S.A. was founded in 1993 and is based in Paris, France. NEOVACS operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 24 people.
Neovacs SA Stock Technical Analysis
Neovacs SA technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
All Next | Launch Module |
Neovacs SA Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neovacs SA's price direction in advance. Along with the technical and fundamental analysis of Neovacs Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neovacs to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0208 | |||
Jensen Alpha | 0.0946 | |||
Total Risk Alpha | (3.60) | |||
Sortino Ratio | 0.0061 | |||
Treynor Ratio | 0.1783 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Neovacs Stock Analysis
When running Neovacs SA's price analysis, check to measure Neovacs SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neovacs SA is operating at the current time. Most of Neovacs SA's value examination focuses on studying past and present price action to predict the probability of Neovacs SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neovacs SA's price. Additionally, you may evaluate how the addition of Neovacs SA to your portfolios can decrease your overall portfolio volatility.